Arthritis Research & Therapy

official impact factor 4.36

Open Access Highly Access

Class-switched B cells display response to therapeutic B-cell depletion in rheumatoid arthritis

Burkhard Möller*, Daniel Aeberli, Stefan Eggli, Martin Fuhrer, Istvan Vajtai, Esther Vögelin, Hans-Rudolf Ziswiler, Clemens A Dahinden and Peter M Villiger

Arthritis Research & Therapy 2009, 11:R62 doi:10.1186/ar2686

Accesses  

  • Last 30 days: 184 accesses
  • Last year: 1641 accesses
  • All time: 6847 accesses

Cited by

BioMed Central: 2 citations

Editorial   Free Highly Accessed

Rituximab treatment in rheumatoid arthritis: how does it work?

Maria JH Boumans, Paul P Tak Arthritis Research & Therapy 2009, 11:134 (24 November 2009)

Research article   Open Access Highly Accessed

Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response

Magda Nakou, Georgios Katsikas, Prodromos Sidiropoulos, George Bertsias, Eva Papadimitraki, Amalia Raptopoulou, Helen Koutala, Helen A Papadaki, Herakles Kritikos, Dimitrios T Boumpas Arthritis Research & Therapy 2009, 11:R131 (28 August 2009)